Spire Healthcare Group (LON:SPI) had its price target boosted by UBS Group from GBX 117 ($1.54) to GBX 121 ($1.59) in a report issued on Tuesday morning, Stock Target Advisor reports. UBS Group currently has a neutral rating on the stock.
Several other research analysts also recently issued reports on SPI. Barclays restated an underweight rating on shares of Spire Healthcare Group in a research report on Tuesday, January 7th. Liberum Capital restated a hold rating on shares of Spire Healthcare Group in a research report on Monday, January 27th. Jefferies Financial Group downgraded Spire Healthcare Group to an underperform rating and lifted their price objective for the stock from GBX 106 ($1.39) to GBX 113 ($1.49) in a research report on Tuesday, January 21st. Peel Hunt restated an add rating on shares of Spire Healthcare Group in a research report on Wednesday, February 5th. Finally, Peel Hunt restated an add rating and set a GBX 155 ($2.04) price objective on shares of Spire Healthcare Group in a research report on Wednesday, January 8th. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. Spire Healthcare Group currently has a consensus rating of Hold and a consensus target price of GBX 130.60 ($1.72).
SPI stock opened at GBX 129.80 ($1.71) on Tuesday. The firm has a 50 day moving average of GBX 135.12 and a 200-day moving average of GBX 120.73. Spire Healthcare Group has a 12-month low of GBX 95.25 ($1.25) and a 12-month high of GBX 145 ($1.91). The company has a current ratio of 1.15, a quick ratio of 0.90 and a debt-to-equity ratio of 120.55. The company has a market cap of $520.60 million and a price-to-earnings ratio of 32.45.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading: What are no-load funds?
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.